Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Laboratory Medicine

Test Directory / Beta-2-Microglobulin

Beta-2-Microglobulin

Brown clotted serum, gel barrier

TestBeta-2-Microglobulin
Common AbbreviationsB2M
ProfileNA
Tube typeBrown clotted serum, gel barrier
Clinical IndicationUsed as a tumour marker in the monitoring of myeloma, lymphoma and leukaemia. Raised levels in renal patients may indicate dialysis-related amyloidosis or transplant rejection. Less commonly, measurement of B2M in serum and urine may be used to distinguish between glomerular and tubular causes of proteinuria.
Specimen TypeBlood
Sample typeSerum
Minimum Volume0.5mL If requesting more than 10 tests please send an additional brown clotted serum sample.
Special PrecautionsNo special requirements
Stability3 days at 2-25°C
Turnaround TimeInpatient: 24 hours Outpatient/ GP: 24 hours
LaboratoryYork
Reference Interval Adults: 0.8 - 2.2 mg/L - New range as of 03/04/18 (Quoted by manufacturer)
LimitationsRaised levels of beta 2 microglobulin may be observed in any condition where there is increased cell turnover or immune activity e.g. CMV and HIV infection, inflammatory and autoimmune disorders.
Notes
Two female receptionists on the phone at a desk smiling

Feedback

Internal hospital signage with arrows to Main Reception, Outpatients and Pharmacy

A-Z of Services

Chinese Poland

View all languages >

Invitation to attend the Trust’s Annual Members Meeting

Trust members and the general public are invited to find out more about their local hospitals by attending the Trust’s virtual Annual Members Meeting (AMM), incorporating the Annual General Meeting (AGM), on Tuesday 26 October 2021, between 11:00am-12:30pm.